COVID-19 Drug API Market, Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: CF4B81896F19EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of COVID-19 Drug API in Global, including the following market information:

Global COVID-19 Drug API Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global COVID-19 Drug API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hydroxychloroquine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of COVID-19 Drug API include Shanghai Zhongxi Sunve Pharma Co., Ltd., Cinkate, Fuan Pharmaceutical Group, Wuhan Wuyao Pharmaceutical Co., Ltd, Shenhua Pharmaceutical Co., Ltd and Chongqing Kangle Pharmaceutical Co., Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the COVID-19 Drug API companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global COVID-19 Drug API Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global COVID-19 Drug API Market Segment Percentages, by Type, 2021 (%)

• Hydroxychloroquine
• Chloroquine Phosphate
• Others

Global COVID-19 Drug API Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global COVID-19 Drug API Market Segment Percentages, by Application, 2021 (%)

• Tablet
• Injection

Global COVID-19 Drug API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global COVID-19 Drug API Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies COVID-19 Drug API revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies COVID-19 Drug API revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Shanghai Zhongxi Sunve Pharma Co., Ltd.
• Cinkate
• Fuan Pharmaceutical Group
• Wuhan Wuyao Pharmaceutical Co., Ltd
• Shenhua Pharmaceutical Co., Ltd
• Chongqing Kangle Pharmaceutical Co., Ltd.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 COVID-19 Drug API Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global COVID-19 Drug API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COVID-19 DRUG API OVERALL MARKET SIZE

2.1 Global COVID-19 Drug API Market Size: 2021 VS 2028
2.2 Global COVID-19 Drug API Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top COVID-19 Drug API Players in Global Market
3.2 Top Global COVID-19 Drug API Companies Ranked by Revenue
3.3 Global COVID-19 Drug API Revenue by Companies
3.4 Top 3 and Top 5 COVID-19 Drug API Companies in Global Market, by Revenue in 2021
3.5 Global Companies COVID-19 Drug API Product Type
3.6 Tier 1, Tier 2 and Tier 3 COVID-19 Drug API Players in Global Market
  3.6.1 List of Global Tier 1 COVID-19 Drug API Companies
  3.6.2 List of Global Tier 2 and Tier 3 COVID-19 Drug API Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global COVID-19 Drug API Market Size Markets, 2021 & 2028
  4.1.2 Hydroxychloroquine
  4.1.3 Chloroquine Phosphate
  4.1.4 Others
4.2 By Type - Global COVID-19 Drug API Revenue & Forecasts
  4.2.1 By Type - Global COVID-19 Drug API Revenue, 2017-2022
  4.2.2 By Type - Global COVID-19 Drug API Revenue, 2023-2028
  4.2.3 By Type - Global COVID-19 Drug API Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global COVID-19 Drug API Market Size, 2021 & 2028
  5.1.2 Tablet
  5.1.3 Injection
5.2 By Application - Global COVID-19 Drug API Revenue & Forecasts
  5.2.1 By Application - Global COVID-19 Drug API Revenue, 2017-2022
  5.2.2 By Application - Global COVID-19 Drug API Revenue, 2023-2028
  5.2.3 By Application - Global COVID-19 Drug API Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global COVID-19 Drug API Market Size, 2021 & 2028
6.2 By Region - Global COVID-19 Drug API Revenue & Forecasts
  6.2.1 By Region - Global COVID-19 Drug API Revenue, 2017-2022
  6.2.2 By Region - Global COVID-19 Drug API Revenue, 2023-2028
  6.2.3 By Region - Global COVID-19 Drug API Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America COVID-19 Drug API Revenue, 2017-2028
  6.3.2 US COVID-19 Drug API Market Size, 2017-2028
  6.3.3 Canada COVID-19 Drug API Market Size, 2017-2028
  6.3.4 Mexico COVID-19 Drug API Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe COVID-19 Drug API Revenue, 2017-2028
  6.4.2 Germany COVID-19 Drug API Market Size, 2017-2028
  6.4.3 France COVID-19 Drug API Market Size, 2017-2028
  6.4.4 U.K. COVID-19 Drug API Market Size, 2017-2028
  6.4.5 Italy COVID-19 Drug API Market Size, 2017-2028
  6.4.6 Russia COVID-19 Drug API Market Size, 2017-2028
  6.4.7 Nordic Countries COVID-19 Drug API Market Size, 2017-2028
  6.4.8 Benelux COVID-19 Drug API Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia COVID-19 Drug API Revenue, 2017-2028
  6.5.2 China COVID-19 Drug API Market Size, 2017-2028
  6.5.3 Japan COVID-19 Drug API Market Size, 2017-2028
  6.5.4 South Korea COVID-19 Drug API Market Size, 2017-2028
  6.5.5 Southeast Asia COVID-19 Drug API Market Size, 2017-2028
  6.5.6 India COVID-19 Drug API Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America COVID-19 Drug API Revenue, 2017-2028
  6.6.2 Brazil COVID-19 Drug API Market Size, 2017-2028
  6.6.3 Argentina COVID-19 Drug API Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa COVID-19 Drug API Revenue, 2017-2028
  6.7.2 Turkey COVID-19 Drug API Market Size, 2017-2028
  6.7.3 Israel COVID-19 Drug API Market Size, 2017-2028
  6.7.4 Saudi Arabia COVID-19 Drug API Market Size, 2017-2028
  6.7.5 UAE COVID-19 Drug API Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Shanghai Zhongxi Sunve Pharma Co., Ltd.
  7.1.1 Shanghai Zhongxi Sunve Pharma Co., Ltd. Corporate Summary
  7.1.2 Shanghai Zhongxi Sunve Pharma Co., Ltd. Business Overview
  7.1.3 Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Major Product Offerings
  7.1.4 Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Revenue in Global Market (2017-2022)
  7.1.5 Shanghai Zhongxi Sunve Pharma Co., Ltd. Key News
7.2 Cinkate
  7.2.1 Cinkate Corporate Summary
  7.2.2 Cinkate Business Overview
  7.2.3 Cinkate COVID-19 Drug API Major Product Offerings
  7.2.4 Cinkate COVID-19 Drug API Revenue in Global Market (2017-2022)
  7.2.5 Cinkate Key News
7.3 Fuan Pharmaceutical Group
  7.3.1 Fuan Pharmaceutical Group Corporate Summary
  7.3.2 Fuan Pharmaceutical Group Business Overview
  7.3.3 Fuan Pharmaceutical Group COVID-19 Drug API Major Product Offerings
  7.3.4 Fuan Pharmaceutical Group COVID-19 Drug API Revenue in Global Market (2017-2022)
  7.3.5 Fuan Pharmaceutical Group Key News
7.4 Wuhan Wuyao Pharmaceutical Co., Ltd
  7.4.1 Wuhan Wuyao Pharmaceutical Co., Ltd Corporate Summary
  7.4.2 Wuhan Wuyao Pharmaceutical Co., Ltd Business Overview
  7.4.3 Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Major Product Offerings
  7.4.4 Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Revenue in Global Market (2017-2022)
  7.4.5 Wuhan Wuyao Pharmaceutical Co., Ltd Key News
7.5 Shenhua Pharmaceutical Co., Ltd
  7.5.1 Shenhua Pharmaceutical Co., Ltd Corporate Summary
  7.5.2 Shenhua Pharmaceutical Co., Ltd Business Overview
  7.5.3 Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Major Product Offerings
  7.5.4 Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Revenue in Global Market (2017-2022)
  7.5.5 Shenhua Pharmaceutical Co., Ltd Key News
7.6 Chongqing Kangle Pharmaceutical Co., Ltd.
  7.6.1 Chongqing Kangle Pharmaceutical Co., Ltd. Corporate Summary
  7.6.2 Chongqing Kangle Pharmaceutical Co., Ltd. Business Overview
  7.6.3 Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Major Product Offerings
  7.6.4 Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Revenue in Global Market (2017-2022)
  7.6.5 Chongqing Kangle Pharmaceutical Co., Ltd. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. COVID-19 Drug API Market Opportunities & Trends in Global Market
Table 2. COVID-19 Drug API Market Drivers in Global Market
Table 3. COVID-19 Drug API Market Restraints in Global Market
Table 4. Key Players of COVID-19 Drug API in Global Market
Table 5. Top COVID-19 Drug API Players in Global Market, Ranking by Revenue (2021)
Table 6. Global COVID-19 Drug API Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global COVID-19 Drug API Revenue Share by Companies, 2017-2022
Table 8. Global Companies COVID-19 Drug API Product Type
Table 9. List of Global Tier 1 COVID-19 Drug API Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 COVID-19 Drug API Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global COVID-19 Drug API Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - COVID-19 Drug API Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - COVID-19 Drug API Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global COVID-19 Drug API Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - COVID-19 Drug API Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - COVID-19 Drug API Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global COVID-19 Drug API Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global COVID-19 Drug API Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global COVID-19 Drug API Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America COVID-19 Drug API Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America COVID-19 Drug API Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe COVID-19 Drug API Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe COVID-19 Drug API Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia COVID-19 Drug API Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia COVID-19 Drug API Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America COVID-19 Drug API Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America COVID-19 Drug API Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa COVID-19 Drug API Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa COVID-19 Drug API Revenue, (US$, Mn), 2023-2028
Table 30. Shanghai Zhongxi Sunve Pharma Co., Ltd. Corporate Summary
Table 31. Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Product Offerings
Table 32. Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Revenue (US$, Mn), (2017-2022)
Table 33. Cinkate Corporate Summary
Table 34. Cinkate COVID-19 Drug API Product Offerings
Table 35. Cinkate COVID-19 Drug API Revenue (US$, Mn), (2017-2022)
Table 36. Fuan Pharmaceutical Group Corporate Summary
Table 37. Fuan Pharmaceutical Group COVID-19 Drug API Product Offerings
Table 38. Fuan Pharmaceutical Group COVID-19 Drug API Revenue (US$, Mn), (2017-2022)
Table 39. Wuhan Wuyao Pharmaceutical Co., Ltd Corporate Summary
Table 40. Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Product Offerings
Table 41. Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Revenue (US$, Mn), (2017-2022)
Table 42. Shenhua Pharmaceutical Co., Ltd Corporate Summary
Table 43. Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Product Offerings
Table 44. Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Revenue (US$, Mn), (2017-2022)
Table 45. Chongqing Kangle Pharmaceutical Co., Ltd. Corporate Summary
Table 46. Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Product Offerings
Table 47. Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. COVID-19 Drug API Segment by Type in 2021
Figure 2. COVID-19 Drug API Segment by Application in 2021
Figure 3. Global COVID-19 Drug API Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global COVID-19 Drug API Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global COVID-19 Drug API Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by COVID-19 Drug API Revenue in 2021
Figure 8. By Type - Global COVID-19 Drug API Revenue Market Share, 2017-2028
Figure 9. By Application - Global COVID-19 Drug API Revenue Market Share, 2017-2028
Figure 10. By Region - Global COVID-19 Drug API Revenue Market Share, 2017-2028
Figure 11. By Country - North America COVID-19 Drug API Revenue Market Share, 2017-2028
Figure 12. US COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 13. Canada COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe COVID-19 Drug API Revenue Market Share, 2017-2028
Figure 16. Germany COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 17. France COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 19. Italy COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 20. Russia COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia COVID-19 Drug API Revenue Market Share, 2017-2028
Figure 24. China COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 25. Japan COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 28. India COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America COVID-19 Drug API Revenue Market Share, 2017-2028
Figure 30. Brazil COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa COVID-19 Drug API Revenue Market Share, 2017-2028
Figure 33. Turkey COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 34. Israel COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 36. UAE COVID-19 Drug API Revenue, (US$, Mn), 2017-2028
Figure 37. Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Cinkate COVID-19 Drug API Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Fuan Pharmaceutical Group COVID-19 Drug API Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Revenue Year Over Year Growth (US$, Mn) & (2017-2022)